Ethmoid sinus cancer is a rare form of cancer that originates in the sinuses, behind the upper nose and between the eyes. Treatment might include surgery, chemotherapy, or radiation therapy. Although ...
LYR-220, Lyra’s second product candidate, is a long-acting anti-inflammatory therapy in development for CRS patients with and without polyps who have recurrent symptoms despite prior ethmoid sinus ...
VenSure and Cube Join the Company’s Portfolio of Localized Drug Delivery Creating an Integrated Offering of ENT Technologies to Treat CRS As many as 1 in 8 adults in the United States suffer from CRS, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results